Pathophysiological Effects Of Rhoa And Rho-Associated Kinase On Cardiovascular System

Anping Cai,Liwen Li,Yingling Zhou
DOI: https://doi.org/10.1097/HJH.0000000000000768
IF: 4.9
2016-01-01
Journal of Hypertension
Abstract:In past decades, growing evidence from basic and clinical researches reveal that small guanosine triphosphate binding protein ras homolog gene family, member A (RhoA) and its main effector Rho-associated kinase (ROCK) play central and complex roles in cardiovascular systems, and increasing RhoA and ROCK activity is associated with a broad range of cardiovascular diseases such as congestive heart failure, atherosclerosis, and hypertension. Favorable outcomes have been observed with ROCK inhibitors treatment. In this review, we briefly summarize the pathophysiological roles of RhoA/ROCK signaling pathway on cardiovascular system, displaying the potential benefits in the cardiovascular system with controlling RhoA/ROCK signaling pathway.
What problem does this paper attempt to address?